Kitahori Y, Cho M, Konishi N, Ohshima M, Matsui E, Ohnishi T, Imai S, Hiasa Y
Nara Prefectural Institute of Public Health, Ohmori-cho, Nara city, Nara 630-8131, Japan.
Int J Oncol. 1998 Sep;13(3):505-11. doi: 10.3892/ijo.13.3.505.
Expression of CD44 isoforms has been reported to be involved in tumor invasion and metastasis in both rodents and man. We earlier documented establishment of rat transplantable thyroid carcinoma lines in vivo from primary lesions induced by a chemical carcinogen. Recently, two lines (L1a-M4 and L2a-M6) were found to spontaneously metastasize to the lung after subcutaneous transplantation. To determine whether CD44 splice variants contribute to their metastatic spread, carcinoma lines with and without lung metastasis were evaluated quantitatively and qualitatively using RT-PCR followed by hybridization and immunohistochemical analyses. The L1a-M4 and L2a-M6 metastatic lines showed significant overexpression of CD44 variant transcripts containing variant exons v4-v6 or v9-v10/v8-v10, respectively, with concomitant reduced levels of standard transcripts. Investigation of the precise composition of alternatively spliced mRNA in normal tissues and carcinoma lines using an exon-specific RT-PCR method, revealed major chain variant transcripts containing v2/v3, v4-v6, v7-v10 and v8-v10 in all specimens. Applying the same RT-PCR analysis to mRNAs derived from cultured cell lines, demonstrated essentially the same pattern. The results suggest that quantitative increase rather than qualitative change in CD44 variant isoforms is associated with the pathogenesis of lung metastasis of rat thyroid carcinomas.
据报道,CD44亚型的表达在啮齿动物和人类中均与肿瘤侵袭和转移有关。我们之前记录了由化学致癌物诱导的原发性病变在体内建立大鼠可移植甲状腺癌系的过程。最近,发现两条细胞系(L1a-M4和L2a-M6)在皮下移植后会自发转移至肺部。为了确定CD44剪接变体是否有助于它们的转移扩散,我们使用逆转录聚合酶链反应(RT-PCR),随后进行杂交和免疫组织化学分析,对有或无肺转移的癌系进行了定量和定性评估。L1a-M4和L2a-M6转移细胞系分别显示含有可变外显子v4-v6或v9-v10/v8-v10的CD44变体转录本显著过表达,同时标准转录本水平降低。使用外显子特异性RT-PCR方法研究正常组织和癌系中可变剪接mRNA的精确组成,结果显示所有标本中主要的链变体转录本包含v2/v3、v4-v6、v7-v10和v8-v10。对来自培养细胞系的mRNA进行相同的RT-PCR分析,结果显示基本相同的模式。这些结果表明,CD44变体亚型的数量增加而非质量变化与大鼠甲状腺癌肺转移的发病机制有关。